Nature Medicine

Nature Medicine is an academic journal publishing research articles, reviews, news and commentaries in the biomedical area, including both basic research and early-phase clinical research. Topics covered include cancer, cardiovascular disease, gene therapy, immunology, vaccines, and neuroscience. The journal seeks to publish research papers that demonstrate novel insight into disease processes, with direct evidence of the physiological relevance of the results. Founded in 1995, Nature Medicine is published by the Nature Publishing Group, a division of Macmillan Publishers Ltd, and is one of the rapidly expanding stable of Nature journals. As with other Nature journals, there is no external Editorial Board, with editorial decisions being made by an in-house team, although peer review by external expert referees forms a part of the review process. Nature Medicine is published monthly. Articles are archived online in text and PDF formats; access is by subscription only. Its 2010 impact factor was 25.430, making it the highest-cited research journal in preclinical medicine. It is also among the highest impact of primary (non-review) scientific journals.

Publisher
Nature Publishing Group
History
1995--present
Website
http://www.nature.com/nm/index.html
Impact factor
25.430 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Oncology & Cancer

AI could predict risk of lung cancer recurrence

Computer scientists working with pathologists have trained an artificial intelligence (AI) tool to determine which patients with lung cancer have a higher risk of their disease coming back after treatment.

Medications

Target trials support drug safety in pregnant patients

Out of concern for fetal safety, pregnant people have typically been excluded from drug trials. And when human health is on the line, drug studies assessing fetal safety in animal models may be viewed as far from definitive.

Diseases, Conditions, Syndromes

Small study suggests COVID-19 antibody test shows promise

A test that can detect the presence of antibodies to the SARS-CoV-2 virus in the blood of human patients is described in Nature Medicine. This assay, tested in 16 patients, may help to identify individuals whose plasma contains ...

Diseases, Conditions, Syndromes

New AI diagnostic can predict COVID-19 without testing

Researchers at King's College London, Massachusetts General Hospital and health science company ZOE have developed an artificial intelligence diagnostic that can predict whether someone is likely to have COVID-19 based on ...

page 1 from 49